New Delhi, 29 March 2025: Heart patients’ treatment bill is set to rise after India’s drug cost regulator allowed manufacturers and importers to increase the price of coronary stents by almost 2 per cent to account for inflation.
 
The National Pharmace......
View Details

Related News

• 529 Drug Samples declared NSQ and 55 Spurious in last three calendar years in Rajasthan: Govt in LS (31-03-2025)

---

• WB writes to Bihar and UP governments about spurious drugs makers (31-03-2025)

---

• Dabur to Drop ‘Anti-Inflammatory’, ‘Anti-Bacterial’, ‘Analgesic’ Claims from Toothpaste Labels by June 2025 (31-03-2025)

---

• Kangra: One person arrested from Delhi in drug case (30-03-2025)

---

• RMSCL to address drugs shortage using automated demand system (30-03-2025)

---

• Raids on chemist shops across Gujarat, 50 lakh Codeine Cough Syrup bottles seized (30-03-2025)

---

• Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer (30-03-2025)

---

• HC asks Centre, Delhi govt to disclose regulatory mechanism for blood banks in city (30-03-2025)

---

• Meghalaya’s Citrus offers hope against antibiotic resistance (30-03-2025)

---

• Counterfeit anti-rabies vaccine circulating in major Indian cities (30-03-2025)

---